| Shellie Theiss, | |
|
4130 Seckinger Ct, Toledo, OH 43613-3617 | |
| (419) 902-1047 | |
| Not Available |
| Full Name | Shellie Theiss |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 4130 Seckinger Ct, Toledo, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134854821 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Provider Name | Prohealth Partners Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1457593774 PECOS PAC ID: 1759428105 Enrollment ID: O20091016000546 |
News Archive
People with a family history of pancreas cancer now have a way to accurately predict their chance of carrying a gene for hereditary pancreas cancer and their lifetime risk of developing the disease.
Dignity Health St. Mary's Medical Center has received the Distinguished Hospital Award for Clinical Excellence™ from Healthgrades, the leading online resource for comprehensive information about physicians and hospitals. This is the second consecutive year St. Mary's has received this award, which recognizes St. Mary's as among the top five percent of more than 4,500 hospitals nationwide for clinical performance.
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today the formation of the company's world renowned Scientific Advisory Board (SAB). The SAB was established to provide miRagen with valuable guidance in developing an extensive pipeline of microRNA-based drugs and is comprised of leaders who are internationally recognized experts in their respective fields.
Interluekin-1α (IL-1α) is an important part of the immune response, but until now it has been unclear how this molecule is processed from its precursor, pro-IL-1α, and exits the cell during inflammasome activation.
With a new $5.8 million, three-year award from the National Institutes of Health, researchers at the University of Pittsburgh School of Medicine will further develop a state-of-the-art, microfluidic 3D model system that mimics structure and function of the liver to better predict organ physiology, assess drug toxicity and build disease models.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shellie Theiss, 4130 Seckinger Ct, Toledo, OH 43613-3617 Ph: (419) 902-1047 | Shellie Theiss, 4130 Seckinger Ct, Toledo, OH 43613-3617 Ph: (419) 902-1047 |
News Archive
People with a family history of pancreas cancer now have a way to accurately predict their chance of carrying a gene for hereditary pancreas cancer and their lifetime risk of developing the disease.
Dignity Health St. Mary's Medical Center has received the Distinguished Hospital Award for Clinical Excellence™ from Healthgrades, the leading online resource for comprehensive information about physicians and hospitals. This is the second consecutive year St. Mary's has received this award, which recognizes St. Mary's as among the top five percent of more than 4,500 hospitals nationwide for clinical performance.
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today the formation of the company's world renowned Scientific Advisory Board (SAB). The SAB was established to provide miRagen with valuable guidance in developing an extensive pipeline of microRNA-based drugs and is comprised of leaders who are internationally recognized experts in their respective fields.
Interluekin-1α (IL-1α) is an important part of the immune response, but until now it has been unclear how this molecule is processed from its precursor, pro-IL-1α, and exits the cell during inflammasome activation.
With a new $5.8 million, three-year award from the National Institutes of Health, researchers at the University of Pittsburgh School of Medicine will further develop a state-of-the-art, microfluidic 3D model system that mimics structure and function of the liver to better predict organ physiology, assess drug toxicity and build disease models.
› Verified 7 days ago
Michael D Iott, ODT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3160 Central Park W, Toledo, OH 43617 Phone: 419-841-1840 Fax: 419-841-1841 | |
Ms. Kay Lynn Dohm, O.T.R.L. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4560 W Alexis Rd, Toledo, OH 43623 Phone: 419-546-0042 | |
Mrs. Nancy Jo Bowman, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1515 Slater St, Toledo, OH 43612 Phone: 419-671-3650 | |
Christine Younger, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3450 W Central Ave Ste 366e, Toledo, OH 43606 Phone: 419-531-2408 | |
Howard Luebke, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3160 Central Park W, Toledo, OH 43617 Phone: 419-841-1840 Fax: 419-841-1841 | |
Kari Dale, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3160 Central Park W, Toledo, OH 43617 Phone: 419-841-1840 Fax: 419-841-1841 | |
Mary Janice Dunstan, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3901 Shadylawn Dr, Toledo, OH 43614 Phone: 419-671-2757 |